Literature DB >> 32638724

A short peptide that preferentially binds c-MYC G-quadruplex DNA.

Aisling Minard1, Danielle Morgan2, Federica Raguseo3, Anna Di Porzio4, Denise Liano1, Andrew G Jamieson2, Marco Di Antonio1.   

Abstract

G-quadruplexes (G4s) are non-canonical DNA secondary structures. The identification of selective tools to probe individual G4s over the ∼700 000 found in the human genome is key to unravel the biological significance of specific G4s. We took inspiration from a crystal structure of the bovine DHX36 helicase bound to the G4 formed in the promoter region of the oncogene c-MYC to identify a short peptide that preferentially binds MYC G4 with nM affinity over a small panel of parallel and non-parallel G4s tested.

Entities:  

Year:  2020        PMID: 32638724     DOI: 10.1039/d0cc02954h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.

Authors:  Sarah K Madden; Aline Dantas de Araujo; Mara Gerhardt; David P Fairlie; Jody M Mason
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

2.  Identification and targeting of G-quadruplex structures in MALAT1 long non-coding RNA.

Authors:  Xi Mou; Shiau Wei Liew; Chun Kit Kwok
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

Review 3.  MYC inhibitors in multiple myeloma.

Authors:  Sandra Martínez-Martín; Laura Soucek
Journal:  Cancer Drug Resist       Date:  2021-08-13

4.  Recognition and unfolding of human telomeric G-quadruplex by short peptide binding identified from the HRDC domain of BLM helicase.

Authors:  Taniya Sharma; Nikita Kundu; Sarvpreet Kaur; Amlan Chakraborty; Aman Kumar Mahto; Rikeshwer Prasad Dewangan; Jadala Shankaraswamy; Sarika Saxena
Journal:  RSC Adv       Date:  2022-08-08       Impact factor: 4.036

Review 5.  The long journey to bring a Myc inhibitor to the clinic.

Authors:  Jonathan R Whitfield; Laura Soucek
Journal:  J Cell Biol       Date:  2021-06-23       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.